# Indigo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/indigo-2

- Industry: Insurance
- Headquarters: Miami, US
- Website: www.getindigo.com/
- Total disclosed funding: $50M
- Latest round: Series B (Jan 29, 2026)
- Investors on record: 3

## About

Headquartered in Miami, US, Indigo Technologies specializes in medical malpractice insurance, providing tailored coverage for physicians across various specialties, leveraging advanced technology to ensure optimal pricing and risk management.Founded in 2023 in Miami, US, Indigo Technologies operates in the medical malpractice insurance sphere. The company was formed to cater specifically to the insurance needs of healthcare professionals. The firm has successfully raised USD 50.00 mn in its Series B funding round led by Rubicon Founders, with participation from Optum Ventures and Town Hall Ventures. This funding marks a notable achievement as it constitutes the total amount raised by the company to date.Indigo specializes in providing comprehensive medical malpractice insurance tailored specifically for physicians across a wide range of medical specialties. The company's core product offering includes customized insurance coverage that leverages artificial intelligence to analyze thousands of real data points, resulting in tailored pricing and coverage solutions that address the unique risks associated with various medical practices. Indigo serves a diverse client base that includes general practitioners, specialists, and surgeons, ensuring that healthcare professionals have the necessary protection to operate with confidence. While Indigo does not currently insure dentists, podiatrists, or chiropractors, its policies are designed to meet the needs of a vast array of medical fields, thus facilitating peace of mind for practitioners. The company markets its products primarily in the United States, focusing on regions with a high concentration of medical professionals requiring robust malpractice insurance.Indigo generates revenue through the sale of its medical malpractice insurance policies, utilizing a direct-to-consumer model that connects physicians with curated insurance brokers from its proprietary network. Clients initiate the process by submitting a request for a quote, which brokers then use to assess individual needs and provide customized policy recommendations. The transaction structure is primarily based on premium payments for the insurance coverage offered, with pricing reflecting the specific specialties and risk profiles of the clients. Indigo's commitment to offering rigorous defense and high-quality coverage is reflected in its competitive positioning within the marketplace, underscored by its A- (Excellent) financial strength rating from AM Best, which affirms the company's stability and trustworthiness as a key player in the medical malpractice insurance sector.Indigo aims to further expand its offerings by developing new insurance products tailored to emerging medical specialties and plans to launch these initiatives by year-end 2024. The company is also targeting expansion into additional markets across the US, particularly in states with growing healthcare sectors, such as Texas and California, by mid-2025. The recent funding of USD 50.00 mn will be utilized to enhance technology infrastructure and support marketing efforts to boost market penetration.

## Funding rounds

- Series B, Jan 29, 2026, $50M — Optum Ventures, Town Hall Ventures, Rubicon Founders

## Investors

- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series B
- Town Hall Ventures (https://capitalatlas.ai/funds/town-hall-ventures) — Series B
- Rubicon Founders (https://capitalatlas.ai/funds/rubicon-founders) — Series B